Tamoxifen Fails to Deliver on Clinical Promise for Duchenne Muscular Dystrophy

(MedPage Today) -- Repurposed tamoxifen failed to delay disease progression as an adjunct to corticosteroids among boys with Duchenne muscular dystrophy (DMD), the phase III TAMDMD trial showed. In an intention-to-treat population, no significant...
Source: MedPage Today Neurology - Category: Neurology Source Type: news